RUNX2 and osteoporosis: The present study determined that expression of osteoblastic markers BMP-2, RUNX2, OSX, ALP, OPN and BSP-1 were significantly decreased in OVX-induced osteoporosis while treating PMT increased those of osteoblastic markers in a dose-dependent manner.